Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never ...

Walgreens is struggling and is considering closing stores and selling assets. It brought on a new CEO last year who appears to be considering a wide range of possible moves for the business ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Walgreens stock is taking a hit, in part, because of prescription reimbursement pressures from insurers. Walgreens also made a poor acquisition that continues to weigh on its results. However, the ...

QuickVue At-Home OTC COVID-19 tests (also sold under the names CVS Health At Home COVID-19 Test Kit and Walgreens At-Home ... The expiration date for BinaxNOW COVID-19 Antigen Self Tests, also ...

Walgreens sees a long runway for its two-year-old clinical trials business as it doubles down on its core retail pharmacy operations. Ramita Tandon, chief clinical trials officer, shared insights ...

SAN FRANCISCO—Private security guard Michael Anthony carried a .40-caliber Glock on his last shift at the Walgreens near Union Square, under fresh orders to crack down on shoplifters.

One day after Walgreens revealed it will close its store at 101 Pattonwood Drive in Irondequoit on Nov. 13, the chain confirmed it will shut down three more stores in the Rochester market ...

But that doesn't mean you should invest in every company you know well. On that note, Walgreens Boots Alliance (NASDAQ: WBA) is a business that many of us are customers of, and often for many years.

As Walgreens Boots Alliance runs out of options to turn itself and its stock price around, so too does the fortune of its single largest shareholder and executive chairman: Stefano Pessina ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...